Synthesis of optically active NC-1800, a therapeutic agent for urinary disturbance

Chemical and Pharmaceutical Bulletin

Volumn 47, Issue 8, 1999, Pages 1154-1156

  Yoshida, Shinichi ^a   Yamamoto, Masao ^b  

^a SAITAMA UNIVERSITY   (Japan)

^b Nippon Chemiphar Co Ltd   (Japan)

Author keywords

Crystallization; NC 1800; Optically active; Oxazolidine; Urinary

Indexed keywords

5 BENZYL 3 (3 MORPHOLINO 1 PHENYLPROPYL) 1,3 OXAZOLIDIN 2 ONE FUMARATE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANDROGEN; CHOLINERGIC RECEPTOR BLOCKING AGENT; OXAZOLIDINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; MICTURITION DISORDER; NONHUMAN; OPTICAL ROTATION; REACTION ANALYSIS; STEREOISOMERISM; STRUCTURE ANALYSIS;

EID: 0032852435     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.47.1154     Document Type: Article

References (3)

1. Motoya T., Shimozono T., Medicine and Drug Journal, 30-S1, 215-220 (1994).
2. Takahashi S., Hasegawa F., Isurugi K., Medicine and Drug Journal, 31-S1, 213-218 (1995).
3. Hayashi K., Matsuoka K., Noda S., Medicine and Drug Journal, 32-S1, 167-171 (1996).